Foundry Partners LLC cut its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 31.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,343 shares of the medical instruments supplier’s stock after selling 4,306 shares during the period. Foundry Partners LLC’s holdings in DENTSPLY SIRONA were worth $606,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of XRAY. Korea Investment CORP increased its position in shares of DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after buying an additional 1,251 shares in the last quarter. Howard Hughes Medical Institute increased its position in shares of DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 1,580 shares in the last quarter. Penserra Capital Management LLC increased its position in shares of DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 240 shares in the last quarter. Howland Capital Management LLC acquired a new position in shares of DENTSPLY SIRONA during the first quarter valued at approximately $203,000. Finally, IBM Retirement Fund increased its position in shares of DENTSPLY SIRONA by 29.9% in the second quarter. IBM Retirement Fund now owns 3,324 shares of the medical instruments supplier’s stock valued at $216,000 after buying an additional 766 shares in the last quarter. 95.13% of the stock is currently owned by institutional investors.

Shares of DENTSPLY SIRONA Inc. (XRAY) opened at 53.17 on Friday. The company’s market capitalization is $12.20 billion. DENTSPLY SIRONA Inc. has a 52-week low of $52.73 and a 52-week high of $65.68. The stock’s 50 day moving average price is $61.68 and its 200-day moving average price is $62.21.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.65. The company had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The firm’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.76 earnings per share. On average, analysts expect that DENTSPLY SIRONA Inc. will post $2.72 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be paid a dividend of $0.0875 per share. The ex-dividend date is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.66%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -10.09%.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.dailypolitical.com/2017/08/18/dentsply-sirona-inc-xray-stake-reduced-by-foundry-partners-llc.html.

Several research analysts have commented on XRAY shares. Stifel Nicolaus reaffirmed a “buy” rating and issued a $66.00 price target (down from $70.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a research report on Thursday, July 13th. Cleveland Research raised DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. HC Wainwright started coverage on DENTSPLY SIRONA in a research report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price target on the stock. Finally, BidaskClub raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, June 30th. Three analysts have rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the stock. DENTSPLY SIRONA has an average rating of “Hold” and an average target price of $66.25.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.